Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
in severe congenital neutropenia (defective dephosphorylation of proteins involved in signaling pathways) | tumoral
| somatic mutation
|  
|  
| gain of function
|
gain of function, in juvenile leukemia, myelomonocytic, rhabdomyosarcoma, myelodysplastic syndrome, acute myeloid leukemia (high phosphatase activity observed in mutations at codons 61, 71, 72, and 76 significantly associated with leukemogenesis) and rarely in solid tumors | tumoral
| somatic mutation
|  
|  
|  
|
in high hyperdiploid childhood acute lymphoblastic leukemia | tumoral
| germinal mutation
|  
|  
| gain of function
|
activating mutations in 3.4p100 of neuroblastomas | constitutional
|  
|  
| --low
|  
|
specifically disrupted extracellular signal-regulated kinase (ERK) signaling in Müller cells, leading to STAT3 activation in photoreceptors | |
| selective deletion of Shp2, in striated muscle results in severe dilated cardiomyopathy in mice, leading to heart failure and premature mortality | |
LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development; transgenic Drosophila expressing the two commonest LS mutations in csw under control of UAS/GAL4 system, ubiquitous expression of those LS-causing alleles resulted in a gain-of-function phenotype, which was similar to that of the Noonan transgenic flies |
|
decreased Igf1 levels in Ptpn11-mutated mice suggesting an involvement of Shp2 in GH signaling |
|
germline mutation Shp2D61G in animal models enhances hematopoietic stem cell activity and induces myeloproliferative disease |